Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
PLGA-TK-PEG2000-SS-31 20000（50:50）
Poly(L-lactide-co-glycolide)-thioketal-Polyethylene glycol-SS-31
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-5419 | 50mg | 950.00 | + Add to cart |
|
| R-C-5419 | 100mg | 1650.00 | + Add to cart |
|
|
||||
Product description
PLGA can encapsulate drugs within its matrix and facilitate their controlled release, making it suitable for sustained drug delivery.The TK sequence helps in specific delivery and accumulation of drugs or therapeutic agents at the desired location.PEGylation improves the stability, solubility, and bioavailability of the compound, as well as reducing non-specific interactions and immunogenicity.SS-31 is a mitochondria-targeting peptide. It specifically targets the mitochondria, the powerhouse of the cell, and has shown potential in protecting against oxidative stress and mitochondrial dysfunction.
| Appearance | N/A |
|---|---|
| PEG Molecular weight | 2000 |
| purity | >95% |
| PDI by GPC | <1.5 |
| Storage | -20℃ protected from light and moisture |
| Transportation | 4-25℃temperature for up to 3 weeks |
| Stability | 1year |
Document
msds----PLGA-TK-PEG2000-SS-31 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
